🇺🇸

US SEC Filing Intelligence

· daily

New Drug Approvals (Original) — September 02, 2026

The September 2, 2026 FDA approval stream featured 14 approvals, all classified as 'Other' (no NME, biosimilar, or label expansion designations in the provided data, though several approvals carry NME, biosimilar, or label expansion characteristics). The period was dominated by biosimilar and generic-type approvals, with notable NME approvals for Takeda's RUSFERTIDE ACETATE (MIMRYLO), Priovant's undisclosed NME, and Revolution Medicines' DARAXONRASIB (RASONQUE), all with Priority Review and Orphan designations. The highest-conviction signal is DARAXONRASIB, a targeted oncology therapy for KRAS-mutant cancers, which could be a significant commercial opportunity for Revolution Medicines. Key risks include the lack of commercial data (sales estimates, pricing) across all approvals, and the potential for biosimilar competition to erode originator revenues for drugs like POMALIDOMIDE, FINERENONE, and EMTRICITABINE. Investors should monitor launch execution and payer coverage for the NMEs, as well as the competitive impact of biosimilars on existing franchises.

14 total filings
· daily

VA Healthcare & Services Contracts — September 02, 2026

Over a single-day period, the Department of Veterans Affairs awarded one contract totaling $143.6 million to Oracle Health Government Services, Inc. for data migration services under the VA’s Electronic Health Record Modernization (OEHRM) program. This is a purely civilian award with no defense exposure, reflecting the VA’s continued investment in IT modernization. The contract is a firm-fixed-price, non-competitive delivery order with a performance period that ended in November 2021, meaning it has no current revenue relevance. The highest-conviction signal is neutral: the sole-source relationship suggests Oracle’s entrenched position, but the expired contract and lack of competition data limit actionable investment implications. Key risk is the absence of any re-compete or follow-on award data, leaving Oracle’s competitive moat unconfirmed for future VA IT contracts.

1 total filings
· daily

New Federal Contractors — September 02, 2026

This digest covers three federal contracts totaling $633.7 million, all awarded to civilian agencies with zero defense-related exposure, signaling a pure civilian-sector procurement theme. The dominant award is a $365.4 million cost-plus delivery order to Booz Allen Hamilton from the GSA for IT systems design, representing 58% of total obligation and carrying moderate execution risk due to 167 subawards. A $143.6 million sole-source VA data migration contract to Oracle Health Government Services is likely completed, offering limited current revenue relevance. The $124.7 million NASA modification to Vertex Aerospace lacks detail, reducing conviction. Key risk: Booz Allen's contract nears expiration in April 2024, creating recompetition uncertainty. Highest-conviction signal is neutral, with no bullish or bearish extremes across the set.

3 total filings
· daily

Significant Contract Modifications ($10M+) — September 02, 2026

This digest covers three significant contract modifications totaling $633.7 million, all from civilian agencies with zero defense-related awards, signaling a clear civilian-sector focus for the period. The dominant theme is federal IT modernization, led by a $365.4 million Booz Allen Hamilton cost-plus award from GSA for IT systems design, which represents the highest-conviction signal due to its size and ongoing federal priorities. However, the Booz Allen contract's negative outlayed amount and heavy subaward reliance introduce execution and margin risks, while the $143.6 million Oracle Health VA contract is largely historical (completed in 2021) and offers limited current relevance. The $124.7 million Vertex Aerospace NASA modification lacks sufficient detail for actionable analysis, but the aggregate neutral signal strength (5.3/10) and lack of bullish or bearish signals suggest a stable but unexciting investment landscape for government services contractors.

3 total filings
· daily

Contract Deobligations Alert — September 02, 2026

The three contracts analyzed represent $633.7 million in total obligations, all from civilian agencies (GSA, VA, NASA), with zero defense-related awards. The dominant theme is federal IT modernization, led by Booz Allen Hamilton's $365.4 million GSA delivery order for IT systems design, which carries the highest materiality (7/10) but shows a negative outlayed amount, signaling potential de-obligation risk. Oracle Health's $143.6 million VA data migration contract is likely completed, offering limited current relevance, while Vertex Aerospace's $124.7 million NASA modification lacks detail. The highest-conviction signal is the continued civilian IT spending, though execution risks and lack of defense exposure temper enthusiasm. Key watch items include Booz Allen's contract recompetition and resolution of its negative outlay.

3 total filings
· daily

Contract Option Exercises — September 02, 2026

The September 2, 2026 option exercise stream totals $633.7 million in obligations, all from civilian agencies (GSA, VA, NASA), with no defense-related awards. The dominant theme is federal IT modernization, led by Booz Allen Hamilton's $365.4 million GSA IT systems design delivery order, which represents the highest-conviction signal (materiality 7/10) but carries execution risk due to heavy subaward reliance and a negative outlayed amount. Oracle Health's $143.6 million VA data migration order is likely completed, limiting current relevance, while Vertex Aerospace's $124.7 million NASA modification lacks detail. Key risks include potential de-obligation on the Booz Allen contract and recompetition pressure as its April 2024 end date approaches. Overall, the stream is neutral, with no bullish or bearish signals, reflecting mature, non-transformative contract actions.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — September 02, 2026

The two contracts analyzed total $509,049,971 in obligations, both from civilian agencies (GSA and VA), with zero defense-related awards. The dominant theme is federal IT modernization, with Booz Allen Hamilton's $365.4M GSA delivery order for IT systems design representing the highest materiality and a stable revenue stream through April 2024, though execution risk is elevated by heavy subaward reliance and a negative outlayed amount. Oracle Health's $143.6M VA data migration task order, awarded non-competitively, signals a sole-source relationship but is likely completed, limiting current investment relevance. The highest-conviction signal is Booz Allen's cost-plus pricing structure, which reduces profit volatility but caps upside, while the key risk is the unresolved negative outlayed amount that may indicate de-obligation trends. Investors should monitor Booz Allen's contract modifications and recompetition announcements as the contract nears expiration, and track VA's future health IT procurements for Oracle's competitive positioning.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — September 02, 2026

The three contracts reviewed total $633.7 million, all civilian, with zero defense exposure—underscoring a pure civilian-agency theme. The highest-conviction signal is Booz Allen Hamilton's $365.4 million GSA award for IT systems design, which represents its largest single contract in this digest but carries execution risk from $113.6 million in subawards and a cost-plus structure limiting margin upside. Oracle Health’s $143.6 million VA data migration contract is non-competitive and likely expired, offering no current revenue visibility. Vertex Aerospace’s $124.7 million NASA modification lacks detailed data, reducing actionable insight. The key risk is that the Booz Allen award's negative outlayed amount could signal de-obligation trends, warranting close monitoring for margin compression or recompetition threats. Overall, the digest reveals moderate, near-term civilian IT spend but no transformative growth catalysts.

3 total filings
· daily

S&P 500 Technology Sector SEC Filings — September 02, 2026

The 13 filings for the S&P 500 Technology stream reveal a sector bifurcated by AI investment. Broadcom's record Q3 FY2026 results, with revenue surging 86% YoY and AI semiconductor revenue up 221% YoY, underscore the massive demand for AI infrastructure. However, a wave of high-profile insider selling—including NVIDIA Director Stevens ($98.5M), Microsoft CEO Nadella ($16.5M), and Synopsys' Executive Chair ($11M)—signals potential caution at the top. Cisco's mixed fiscal 2026 results show solid revenue growth of 12% YoY but are tempered by a 0.4-point gross margin decline and inventories doubling, hinting at supply chain pressures. Microsoft's segment restructuring into 'Agents and Infra' and 'Devices and Consumer' for FY2027 is a strategic pivot to capture the AI agent era. The dominant theme is that while AI-fueled growth is explosive, insiders are taking profits, and legacy hardware players face margin and inventory headwinds.

11 high priority 2 medium 13 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 02, 2026

The 18 filings from NASDAQ-100 constituents reveal a powerful bifurcation between AI-driven growth and legacy business challenges. Broadcom's record Q3 FY2026 results, with revenue surging 86% YoY and AI semiconductor revenue up 221%, underscore the massive capital reallocation toward AI infrastructure. However, Cisco's mixed fiscal 2026 results, with a 0.4-point gross margin decline and inventories doubling, highlight supply chain and demand headwinds in networking. Insider activity is a key theme: heavy selling by top executives at Microsoft (CEO Satya Nadella sold ~$16.5M), NVIDIA (Director Mark Stevens sold ~$98.5M), and Gilead Sciences (CEO Daniel O'Day sold ~$1.19M) signals potential valuation concerns or profit-taking at elevated levels. Meanwhile, Netflix's board-wide option awards (9 directors and the CAO receiving ~774-902 options each) suggest a retention-focused compensation strategy. A critical portfolio-level pattern is the divergence in capital allocation: Broadcom is generating massive free cash flow ($13.7B, 46% of revenue) while Cisco's operating cash flow is flat, and Microsoft is restructuring its reporting segments to emphasize AI. The most actionable insight is the contrast between Broadcom's accelerating AI momentum and the insider selling at NVIDIA and Microsoft, which may indicate a sector rotation within tech.

6 high priority 12 medium 18 total filings
· daily

High-Value Federal Grants ($5M+) — September 02, 2026

The three contracts analyzed total $633.7 million in obligations, all from civilian agencies (0% defense-related), signaling continued federal investment in IT modernization and data migration outside the defense sector. The dominant theme is civilian IT services, led by a $365.4 million GSA award to Booz Allen Hamilton for IT systems design, followed by a $143.6 million VA task order to Oracle Health Government Services for data migration, and a $124.7 million NASA modification to Vertex Aerospace. The highest-conviction signal is Booz Allen's substantial revenue stream, though execution risk from heavy subaward reliance and a negative outlayed amount warrant caution. Key risks include potential de-obligation trends and the expiration of Booz Allen's contract in April 2024, which could trigger a recompetition. Overall, the digest reflects stable civilian IT spending but limited transformative upside, with no defense exposure in this period.

3 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 02, 2026

This digest of 48 filings reveals a bifurcated activist landscape: aggressive, high-conviction moves by major holders like Advent International (Definitive Healthcare) and Saba Capital (BlackRock ESG Term Trust) contrast with passive institutional stake-building in ETFs and infrastructure funds. The most critical development is the potential take-private of Definitive Healthcare at $1.02/share, a 58.5% holder-led bid with insider rollover, signaling deep value. A significant pattern emerges in the SPAC and blank-check space, with three separate filers (Great Point, Deep Track, Commodore) all accumulating 5-6% passive stakes in JATT III Acquisition Corp, suggesting a coordinated or thematic bet on a deSPAC catalyst. Insider selling is notable but largely explained by estate planning (Tutor Perini) and warrant restructuring (Carvana/Root). The withdrawal of TDS's proposal to acquire Array's remaining shares is a major strategic reversal, creating uncertainty for minority holders. Capital allocation is mixed, with a $7.7M preferred equity injection into Valion Bio (Tivic Health) and a $55M structured investment in Accuray with significant execution risk. Overall, the data points to a market where large holders are forcing action (go-private bids, board engagement) while passive investors rotate into defined-outcome ETFs and infrastructure, signaling a risk-off tilt within the active opportunity set.

23 high priority 25 medium 48 total filings
· daily

General Federal Contracts — September 02, 2026

The three contracts analyzed, totaling $633.7 million, are entirely civilian in nature, with zero defense exposure, signaling a concentrated opportunity in federal IT modernization and healthcare data migration. The dominant theme is civilian agency IT systems design, led by a $365.4 million GSA award to Booz Allen Hamilton, which represents the highest-conviction signal due to its size and ongoing performance period, though execution risk from heavy subcontractor reliance ($113.6M in subawards) tempers the bullish case. A $143.6 million sole-source VA data migration contract to Oracle Health Government Services, now expired, highlights past competitive moats but offers no current revenue relevance. The key risk is the negative outlayed amount on the Booz Allen contract, which warrants monitoring for potential de-obligation or budget reallocation under a Continuing Resolution scenario.

3 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 02, 2026

The 21 filings for the S&P 500 Financials sector reveal a sector bifurcated between steady, large-cap insurers/processors exhibiting neutral to negative insider activity, and a highly concentrated operational risk within the commercial mortgage-backed securities (CMBS) market. The dominant narrative is a massive, coordinated transfer of special servicing rights for approximately $20.7 billion in CMBS loans from Greystone Servicing to C-IV Asset Management across 9 separate trust filings. While presented as a routine transaction, the enriched data shows the actively specially serviced (distressed) portfolio has more than doubled from $969 million to $2.1 billion over 18 months, indicating a sharp rise in commercial real estate (CRE) distress. Insider activity is predominantly negative or neutral, with CEOs at Progressive and Visa executing large, planned sales, and a 10% owner of Aflac also selling. MetLife shows several executives having shares withheld for taxes. Only a minuscule insider buy from an Interactive Brokers director provides a positive signal, undermining management conviction across the sector. No forward guidance, significant capital allocation news, or scheduled events were reported, suggesting a period of operational quietude ahead of potential stress in CRE portfolios.

10 high priority 11 medium 21 total filings
· daily

All NASA Contracts — September 02, 2026

This digest covers a single NASA contract modification awarded to Vertex Aerospace LLC on June 5, 2013, with a total obligation of $124,693,723. The contract is entirely civilian (NASA), with no defense-related component, and carries a neutral signal strength of 5/10 and materiality of 5/10. The lack of competitive, pricing, or revenue data limits actionable insights, but the size of the award suggests ongoing support services for NASA operations. Key risks include potential budget uncertainty under a continuing resolution (CR) and the absence of competitive dynamics, which may indicate a sole-source or follow-on arrangement. Investors should monitor NASA's fiscal year 2027 budget and any re-compete timelines for this contract vehicle.

1 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 02, 2026

The five filings from the S&P 500 Energy sector today reveal a sector bifurcated between routine insider compensation at ConocoPhillips and a small but symbolic insider purchase at Texas Pacific Land Corp, contrasted with a notable insider sale at Williams Companies. The ConocoPhillips filings (three stock unit awards to senior executives) signal standard long-term incentive alignment with no immediate market signal, while the Williams Companies sale by the SVP & General Counsel, though modest in size, introduces a cautionary tone given its negative sentiment. The Texas Pacific Land Corp purchase by a major 10% owner, Horizon Kinetics, is a tiny transaction but carries positive sentiment as a vote of confidence from a large strategic holder. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in these filings, limiting the depth of trend analysis. Overall, the sector shows no alarming insider distress but also lacks aggressive bullish signals, suggesting a wait-and-see posture among executives.

5 high priority 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — September 02, 2026

The September 2, 2026, batch of Consumer Staples filings reveals a sector in a quiet period of internal restructuring and capital stewardship, with no major earnings reports or guidance updates. The dominant theme is insider capital movements, highlighted by a significant $1.26M sale from Hershey's 10% owner (the Milton Hershey School Trust) under a 10b5-1 plan, which, while pre-planned, signals a steady distribution of the company's massive long-term holdings. Conversely, Kroger's board is signaling alignment through a series of phantom stock awards to directors, including a notable $26.8K grant to Director Sargent, while the company also poaches a top Walmart executive (Mark Ibbotson) to lead store operations, indicating a strategic push for omnichannel excellence. At J.M. Smucker, two C-suite officers (Chief People Officer and Chief Legal Officer) had shares withheld for taxes, a routine but sizable transaction totaling $400K. The most actionable takeaway is the contrast between Hershey's structural insider selling and Kroger's aggressive talent acquisition and director incentives, suggesting divergent paths: Hershey as a stable cash cow and Kroger as a company investing in operational transformation.

10 high priority 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 02, 2026

The four filings from S&P 500 Industrials constituents reveal a sector characterized by muted insider activity and isolated governance issues, with no major period-over-period financial trends or forward-looking guidance changes to drive broad sector-level themes. Insider transactions at Deere & Co. show a senior executive executing a large, pre-planned stock sale, which, while not necessarily alarming, warrants monitoring for any pattern of insider de-risking. The insider award at CSX Corp is a routine compensation event, offering no actionable signal. A significant governance risk has emerged at FedEx Freight, where an executive was terminated for a Code of Conduct violation, creating operational uncertainty. A minor insider gift at Paychex is a non-event. The overall digest is thin on high-conviction, data-driven signals, with the FedEx Freight event being the most actionable item for risk management. The lack of strong bullish or bearish signals from period comparisons or guidance suggests a 'show-me' environment where company-specific execution is paramount.

3 high priority 1 medium 4 total filings
· daily

US Material Events SEC 8-K Filings — September 02, 2026

The September 2, 2026, filings reveal a market bifurcated between aggressive corporate action and underlying financial distress. A clear theme is the pursuit of growth through M&A, with large-cap industrial Vertiv ($1.45B deal for UIG) and smaller players like EVI Industries, cbdMD, and SPACs leading the charge, while G-III Apparel strengthens its portfolio via the Marc Jacobs acquisition. Countering this, a wave of financing events—from stock offerings (PMV Pharmaceuticals) and dilutive note agreements (Senti Biosciences, VolitionRx) to a significant SPAC deal termination (Quantumsphere Acquisition)—highlights acute capital constraints, particularly in the biotech and small-cap space. Operational results are mixed; Daktronics shows a 21% YoY EPS jump but a 20% YoY slump in new orders, signaling potential future revenue headwinds. A massive shakeup in leadership is also underway, with significant C-suite and board changes at major firms like Lowe's, Hershey, and AIG, alongside a wave of director resignations at smaller firms. The period-over-period data, where available, points to margin expansion for some (G-III's 440bps gross margin improvement) but growing stress in order books and balance sheets for others, suggesting investors should prioritize companies with strong operational momentum and clear, executable strategies over those relying on external financing for survival.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 02, 2026

Today's insider trading digest reveals a bifurcated landscape: broad-based equity awards at Taiwan Semiconductor (20 filings, all neutral) signal routine retention, while notable insider selling at Sea Ltd, Deere & Co, and Watts Water Technologies flags potential caution. The most significant capital allocation signal is a $40M insider purchase by a 10% owner at AMG Pantheon Infrastructure Fund, indicating strong conviction. Insider buying at RGC Resources and Granite Ridge Resources suggests value opportunities in small-cap energy and utilities. Period-over-period comparisons are limited as most filings lack historical context, but the prevalence of Rule 10b5-1 plan sales (Sea Ltd, Deere, MKS Inc, Verizon, Teradyne) indicates pre-planned, non-reactive selling. The digest highlights a mix of routine compensation awards and a few high-conviction insider moves that warrant attention.

50 high priority 50 total filings